S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Synta Reports Third Quarter Financial Results and Provides Corporate Update|
|Synta Strengthens Management Team with Two Executive Appointments|
|Synta Announces Presentation on Hsp90 inhibitor Drug Conjugate Platform at 26th EORTC-NCI-AACR Symposium|
|Synta Announces FDA’s Oncologic Drugs Advisory Committee to Discuss Pediatric Uses for Ganetespib|
|Synta Announces Initiation of I-SPY 2 TRIAL of Ganetespib in Breast Cancer|
|Synta Reports Inducement Grants to New Chief Operating Officer and New Chief Financial Officer|
|Synta Announces Presentation of Results from an Investigator-Sponsored Phase 1 Trial of Ganetespib in HER2+ Metastatic Breast Cancer at the 2014 San Antonio Breast Cancer Symposium|
|Synta to Host Conference Call and Webcast of Third Quarter 2014 Financial Results on November 6, 2014|
|Synta to Present at the Stifel 2014 Healthcare Conference|
|AVEO Announces Executive Transition and Corporate Restructuring|
Click above to view more mutual fund data and stats for snta - Synta Pharmaceuticals Inc.